GQG Partners
BIO icon

GQG Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History

GQG Partners’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-347
Closed -$259K – 86
2021
Q3 		$259K Buy
+347
New +$260K ﹤0.01% 83
2020
Q4 		– Sell
-354,266
Closed -$183M – 63
2020
Q3 		$183M Buy
354,266
+58,693
+20% +$29.7M 0.62% 41
2020
Q2 		$133M Buy
+295,573
New +$130M 0.59% 41
2020
Q1 		– Sell
-568
Closed -$210K – 63
2019
Q4 		$210K Buy
+568
New +$200K ﹤0.01% 57

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return